ArticleInternational journal of molecular sciences2023

Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes.

Lorenzo Flori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.